The role of surgery in advanced and recurrent ovarian cancer
Open Access
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 17 (suppl_10) , x234-x240
- https://doi.org/10.1093/annonc/mdl266
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Secondary Surgical Cytoreduction for Advanced Ovarian CarcinomaNew England Journal of Medicine, 2004
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- A Critique of Surgical Cytoreduction in Advanced Ovarian CancerGynecologic Oncology, 2000
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- Extensive Primary Cytoreductive Surgery for Advanced Epithelial Ovarian CancerGynecologic Oncology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective studyGynecologic Oncology, 1986